Interleukin-2 in metastatic melanoma: establishing a role.
Atkins
M B
MB
D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005544:Forecasting; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D008545:Melanoma / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins